Sana Biotechnology (SANA)
(Real Time Quote from BATS)
$3.08 USD
-1.17 (-27.53%)
Updated Aug 7, 2025 10:08 AM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SANA 3.08 -1.17(-27.53%)
Will SANA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SANA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SANA
SANA Gears Up to Report Q4 Earnings: What's in the Cards?
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data
SANA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Sana (SANA) Could be Great Choice for a Bottom Fisher
Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround
Other News for SANA
Sana Biotechnology (SANA) Executes $75M Share Offering at $3.35 per Share
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Sana Biotechnology 20.9M share Spot Secondary priced at $3.35
Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket